https://keshavmed.com/news/eclinicalmedicine%ef%bc%9a%e9%ab%98%e9%a2%91%e4%b8%8d%e5%8f%af%e9%80%86%e7%94%b5%e7%a9%bf%e5%ad%94%e6%b2%bb%e7%96%97%e8%89%af%e6%80%a7%e5%89%8d%e5%88%97%e8%85%ba%e5%a2%9e%e7%94%9f%e7%96%97%e6%95%88-zh/ 2026-07-11T06:34:56+00:00 https://keshavmed.com/news/eclinicalmedicine%ef%bc%9a%e9%ab%98%e9%a2%91%e4%b8%8d%e5%8f%af%e9%80%86%e7%94%b5%e7%a9%bf%e5%ad%94%e6%b2%bb%e7%96%97%e8%89%af%e6%80%a7%e5%89%8d%e5%88%97%e8%85%ba%e5%a2%9e%e7%94%9f%e7%96%97%e6%95%88-en/ 2026-07-11T06:34:56+00:00 https://keshavmed.com/news/eclinicalmedicine%ef%bc%9a%e9%ab%98%e9%a2%91%e4%b8%8d%e5%8f%af%e9%80%86%e7%94%b5%e7%a9%bf%e5%ad%94%e6%b2%bb%e7%96%97%e8%89%af%e6%80%a7%e5%89%8d%e5%88%97%e8%85%ba%e5%a2%9e%e7%94%9f%e7%96%97%e6%95%88-fr/ 2026-07-11T06:34:55+00:00 https://keshavmed.com/news/eclinicalmedicine%ef%bc%9a%e9%ab%98%e9%a2%91%e4%b8%8d%e5%8f%af%e9%80%86%e7%94%b5%e7%a9%bf%e5%ad%94%e6%b2%bb%e7%96%97%e8%89%af%e6%80%a7%e5%89%8d%e5%88%97%e8%85%ba%e5%a2%9e%e7%94%9f%e7%96%97%e6%95%88-de/ 2026-07-11T06:34:55+00:00 https://keshavmed.com/news/eclinicalmedicine%ef%bc%9a%e9%ab%98%e9%a2%91%e4%b8%8d%e5%8f%af%e9%80%86%e7%94%b5%e7%a9%bf%e5%ad%94%e6%b2%bb%e7%96%97%e8%89%af%e6%80%a7%e5%89%8d%e5%88%97%e8%85%ba%e5%a2%9e%e7%94%9f%e7%96%97%e6%95%88-ja/ 2026-07-11T06:34:55+00:00 https://keshavmed.com/news/eclinicalmedicine%ef%bc%9a%e9%ab%98%e9%a2%91%e4%b8%8d%e5%8f%af%e9%80%86%e7%94%b5%e7%a9%bf%e5%ad%94%e6%b2%bb%e7%96%97%e8%89%af%e6%80%a7%e5%89%8d%e5%88%97%e8%85%ba%e5%a2%9e%e7%94%9f%e7%96%97%e6%95%88-pt/ 2026-07-11T06:34:55+00:00 https://keshavmed.com/news/eclinicalmedicine%ef%bc%9a%e9%ab%98%e9%a2%91%e4%b8%8d%e5%8f%af%e9%80%86%e7%94%b5%e7%a9%bf%e5%ad%94%e6%b2%bb%e7%96%97%e8%89%af%e6%80%a7%e5%89%8d%e5%88%97%e8%85%ba%e5%a2%9e%e7%94%9f%e7%96%97%e6%95%88-es/ 2026-07-11T06:34:55+00:00 https://keshavmed.com/news/eclinicalmedicine%ef%bc%9a%e9%ab%98%e9%a2%91%e4%b8%8d%e5%8f%af%e9%80%86%e7%94%b5%e7%a9%bf%e5%ad%94%e6%b2%bb%e7%96%97%e8%89%af%e6%80%a7%e5%89%8d%e5%88%97%e8%85%ba%e5%a2%9e%e7%94%9f%e7%96%97%e6%95%88-ar/ 2026-07-11T06:34:55+00:00 https://keshavmed.com/news/eclinicalmedicine%ef%bc%9a%e9%ab%98%e9%a2%91%e4%b8%8d%e5%8f%af%e9%80%86%e7%94%b5%e7%a9%bf%e5%ad%94%e6%b2%bb%e7%96%97%e8%89%af%e6%80%a7%e5%89%8d%e5%88%97%e8%85%ba%e5%a2%9e%e7%94%9f%e7%96%97%e6%95%88-ru/ 2026-07-11T06:34:55+00:00 https://keshavmed.com/news/eclinicalmedicine%ef%bc%9a%e9%ab%98%e9%a2%91%e4%b8%8d%e5%8f%af%e9%80%86%e7%94%b5%e7%a9%bf%e5%ad%94%e6%b2%bb%e7%96%97%e8%89%af%e6%80%a7%e5%89%8d%e5%88%97%e8%85%ba%e5%a2%9e%e7%94%9f%e7%96%97%e6%95%88-id/ 2026-07-11T06:34:55+00:00 https://keshavmed.com/news/eclinicalmedicine%ef%bc%9a%e9%ab%98%e9%a2%91%e4%b8%8d%e5%8f%af%e9%80%86%e7%94%b5%e7%a9%bf%e5%ad%94%e6%b2%bb%e7%96%97%e8%89%af%e6%80%a7%e5%89%8d%e5%88%97%e8%85%ba%e5%a2%9e%e7%94%9f%e7%96%97%e6%95%88-th/ 2026-07-11T06:34:55+00:00 https://keshavmed.com/news/eclinicalmedicine%ef%bc%9a%e9%ab%98%e9%a2%91%e4%b8%8d%e5%8f%af%e9%80%86%e7%94%b5%e7%a9%bf%e5%ad%94%e6%b2%bb%e7%96%97%e8%89%af%e6%80%a7%e5%89%8d%e5%88%97%e8%85%ba%e5%a2%9e%e7%94%9f%e7%96%97%e6%95%88-vi/ 2026-07-11T06:34:55+00:00 https://keshavmed.com/news/eclinicalmedicine%ef%bc%9a%e9%ab%98%e9%a2%91%e4%b8%8d%e5%8f%af%e9%80%86%e7%94%b5%e7%a9%bf%e5%ad%94%e6%b2%bb%e7%96%97%e8%89%af%e6%80%a7%e5%89%8d%e5%88%97%e8%85%ba%e5%a2%9e%e7%94%9f%e7%96%97%e6%95%88-ms/ 2026-07-11T06:34:55+00:00 https://keshavmed.com/news/angiodynamics%e5%85%ac%e5%8f%b8%e5%ae%a3%e5%b8%83%ef%bc%8c%e5%85%b6%e7%94%a8%e4%ba%8e%e8%af%84%e4%bc%b0nanoknife%e4%b8%8d%e5%8f%af%e9%80%86%e7%94%b5%e7%a9%bf%e5%ad%94%ef%bc%88ire%ef%bc%89%e5%b9%b3/ 2026-07-11T06:34:55+00:00 https://keshavmed.com/news/angiodynamics%e5%85%ac%e5%8f%b8%e5%ae%a3%e5%b8%83%ef%bc%8c%e5%85%b6%e7%94%a8%e4%ba%8e%e8%af%84%e4%bc%b0nanoknife%e4%b8%8d%e5%8f%af%e9%80%86%e7%94%b5%e7%a9%bf%e5%ad%94%ef%bc%88ire%ef%bc%89%e5%b9%b3-zh/ 2026-07-11T06:34:55+00:00 https://keshavmed.com/news/angiodynamics%e5%85%ac%e5%8f%b8%e5%ae%a3%e5%b8%83%ef%bc%8c%e5%85%b6%e7%94%a8%e4%ba%8e%e8%af%84%e4%bc%b0nanoknife%e4%b8%8d%e5%8f%af%e9%80%86%e7%94%b5%e7%a9%bf%e5%ad%94%ef%bc%88ire%ef%bc%89%e5%b9%b3-en/ 2026-07-11T06:34:55+00:00 https://keshavmed.com/news/angiodynamics%e5%85%ac%e5%8f%b8%e5%ae%a3%e5%b8%83%ef%bc%8c%e5%85%b6%e7%94%a8%e4%ba%8e%e8%af%84%e4%bc%b0nanoknife%e4%b8%8d%e5%8f%af%e9%80%86%e7%94%b5%e7%a9%bf%e5%ad%94%ef%bc%88ire%ef%bc%89%e5%b9%b3-ja/ 2026-07-11T06:34:54+00:00 https://keshavmed.com/news/angiodynamics%e5%85%ac%e5%8f%b8%e5%ae%a3%e5%b8%83%ef%bc%8c%e5%85%b6%e7%94%a8%e4%ba%8e%e8%af%84%e4%bc%b0nanoknife%e4%b8%8d%e5%8f%af%e9%80%86%e7%94%b5%e7%a9%bf%e5%ad%94%ef%bc%88ire%ef%bc%89%e5%b9%b3-pt/ 2026-07-11T06:34:54+00:00 https://keshavmed.com/news/angiodynamics%e5%85%ac%e5%8f%b8%e5%ae%a3%e5%b8%83%ef%bc%8c%e5%85%b6%e7%94%a8%e4%ba%8e%e8%af%84%e4%bc%b0nanoknife%e4%b8%8d%e5%8f%af%e9%80%86%e7%94%b5%e7%a9%bf%e5%ad%94%ef%bc%88ire%ef%bc%89%e5%b9%b3-es/ 2026-07-11T06:34:54+00:00 https://keshavmed.com/news/angiodynamics%e5%85%ac%e5%8f%b8%e5%ae%a3%e5%b8%83%ef%bc%8c%e5%85%b6%e7%94%a8%e4%ba%8e%e8%af%84%e4%bc%b0nanoknife%e4%b8%8d%e5%8f%af%e9%80%86%e7%94%b5%e7%a9%bf%e5%ad%94%ef%bc%88ire%ef%bc%89%e5%b9%b3-ar/ 2026-07-11T06:34:54+00:00 https://keshavmed.com/news/angiodynamics%e5%85%ac%e5%8f%b8%e5%ae%a3%e5%b8%83%ef%bc%8c%e5%85%b6%e7%94%a8%e4%ba%8e%e8%af%84%e4%bc%b0nanoknife%e4%b8%8d%e5%8f%af%e9%80%86%e7%94%b5%e7%a9%bf%e5%ad%94%ef%bc%88ire%ef%bc%89%e5%b9%b3-ru/ 2026-07-11T06:34:54+00:00 https://keshavmed.com/news/angiodynamics%e5%85%ac%e5%8f%b8%e5%ae%a3%e5%b8%83%ef%bc%8c%e5%85%b6%e7%94%a8%e4%ba%8e%e8%af%84%e4%bc%b0nanoknife%e4%b8%8d%e5%8f%af%e9%80%86%e7%94%b5%e7%a9%bf%e5%ad%94%ef%bc%88ire%ef%bc%89%e5%b9%b3-id/ 2026-07-11T06:34:54+00:00 https://keshavmed.com/news/angiodynamics%e5%85%ac%e5%8f%b8%e5%ae%a3%e5%b8%83%ef%bc%8c%e5%85%b6%e7%94%a8%e4%ba%8e%e8%af%84%e4%bc%b0nanoknife%e4%b8%8d%e5%8f%af%e9%80%86%e7%94%b5%e7%a9%bf%e5%ad%94%ef%bc%88ire%ef%bc%89%e5%b9%b3-th/ 2026-07-11T06:34:54+00:00 https://keshavmed.com/news/angiodynamics%e5%85%ac%e5%8f%b8%e5%ae%a3%e5%b8%83%ef%bc%8c%e5%85%b6%e7%94%a8%e4%ba%8e%e8%af%84%e4%bc%b0nanoknife%e4%b8%8d%e5%8f%af%e9%80%86%e7%94%b5%e7%a9%bf%e5%ad%94%ef%bc%88ire%ef%bc%89%e5%b9%b3-vi/ 2026-07-11T06:34:54+00:00 https://keshavmed.com/news/angiodynamics%e5%85%ac%e5%8f%b8%e5%ae%a3%e5%b8%83%ef%bc%8c%e5%85%b6%e7%94%a8%e4%ba%8e%e8%af%84%e4%bc%b0nanoknife%e4%b8%8d%e5%8f%af%e9%80%86%e7%94%b5%e7%a9%bf%e5%ad%94%ef%bc%88ire%ef%bc%89%e5%b9%b3-ms/ 2026-07-11T06:34:54+00:00 https://keshavmed.com/news/histosonics%e5%ae%8c%e6%88%90%e9%a6%96%e6%89%b9%e6%82%a3%e8%80%85%e6%b2%bb%e7%96%97%ef%bc%8c%e4%bb%a5%e8%af%84%e4%bc%b0edison%e7%bb%84%e7%bb%87%e7%a2%8e%e5%8c%96%e7%b3%bb%e7%bb%9f%e5%9c%a8/ 2026-07-11T06:34:54+00:00 https://keshavmed.com/news/histosonics%e5%ae%8c%e6%88%90%e9%a6%96%e6%89%b9%e6%82%a3%e8%80%85%e6%b2%bb%e7%96%97%ef%bc%8c%e4%bb%a5%e8%af%84%e4%bc%b0edison%e7%bb%84%e7%bb%87%e7%a2%8e%e5%8c%96%e7%b3%bb%e7%bb%9f%e5%9c%a8-zh-tw/ 2026-07-11T06:34:54+00:00 https://keshavmed.com/news/histosonics%e5%ae%8c%e6%88%90%e9%a6%96%e6%89%b9%e6%82%a3%e8%80%85%e6%b2%bb%e7%96%97%ef%bc%8c%e4%bb%a5%e8%af%84%e4%bc%b0edison%e7%bb%84%e7%bb%87%e7%a2%8e%e5%8c%96%e7%b3%bb%e7%bb%9f%e5%9c%a8-en/ 2026-07-11T06:34:54+00:00 https://keshavmed.com/news/histosonics%e5%ae%8c%e6%88%90%e9%a6%96%e6%89%b9%e6%82%a3%e8%80%85%e6%b2%bb%e7%96%97%ef%bc%8c%e4%bb%a5%e8%af%84%e4%bc%b0edison%e7%bb%84%e7%bb%87%e7%a2%8e%e5%8c%96%e7%b3%bb%e7%bb%9f%e5%9c%a8-fr/ 2026-07-11T06:34:54+00:00 https://keshavmed.com/news/angiodynamics%e5%85%ac%e5%8f%b8%e5%ae%a3%e5%b8%83%ef%bc%8c%e5%85%b6%e7%94%a8%e4%ba%8e%e8%af%84%e4%bc%b0nanoknife%e4%b8%8d%e5%8f%af%e9%80%86%e7%94%b5%e7%a9%bf%e5%ad%94%ef%bc%88ire%ef%bc%89%e5%b9%b3-fr/ 2026-07-11T06:34:54+00:00 https://keshavmed.com/news/angiodynamics%e5%85%ac%e5%8f%b8%e5%ae%a3%e5%b8%83%ef%bc%8c%e5%85%b6%e7%94%a8%e4%ba%8e%e8%af%84%e4%bc%b0nanoknife%e4%b8%8d%e5%8f%af%e9%80%86%e7%94%b5%e7%a9%bf%e5%ad%94%ef%bc%88ire%ef%bc%89%e5%b9%b3-de/ 2026-07-11T06:34:54+00:00 https://keshavmed.com/news/histosonics%e5%ae%8c%e6%88%90%e9%a6%96%e6%89%b9%e6%82%a3%e8%80%85%e6%b2%bb%e7%96%97%ef%bc%8c%e4%bb%a5%e8%af%84%e4%bc%b0edison%e7%bb%84%e7%bb%87%e7%a2%8e%e5%8c%96%e7%b3%bb%e7%bb%9f%e5%9c%a8-es/ 2026-07-11T06:34:53+00:00 https://keshavmed.com/news/histosonics%e5%ae%8c%e6%88%90%e9%a6%96%e6%89%b9%e6%82%a3%e8%80%85%e6%b2%bb%e7%96%97%ef%bc%8c%e4%bb%a5%e8%af%84%e4%bc%b0edison%e7%bb%84%e7%bb%87%e7%a2%8e%e5%8c%96%e7%b3%bb%e7%bb%9f%e5%9c%a8-ar/ 2026-07-11T06:34:53+00:00 https://keshavmed.com/news/histosonics%e5%ae%8c%e6%88%90%e9%a6%96%e6%89%b9%e6%82%a3%e8%80%85%e6%b2%bb%e7%96%97%ef%bc%8c%e4%bb%a5%e8%af%84%e4%bc%b0edison%e7%bb%84%e7%bb%87%e7%a2%8e%e5%8c%96%e7%b3%bb%e7%bb%9f%e5%9c%a8-ru/ 2026-07-11T06:34:53+00:00 https://keshavmed.com/news/histosonics%e5%ae%8c%e6%88%90%e9%a6%96%e6%89%b9%e6%82%a3%e8%80%85%e6%b2%bb%e7%96%97%ef%bc%8c%e4%bb%a5%e8%af%84%e4%bc%b0edison%e7%bb%84%e7%bb%87%e7%a2%8e%e5%8c%96%e7%b3%bb%e7%bb%9f%e5%9c%a8-id/ 2026-07-11T06:34:53+00:00 https://keshavmed.com/news/histosonics%e5%ae%8c%e6%88%90%e9%a6%96%e6%89%b9%e6%82%a3%e8%80%85%e6%b2%bb%e7%96%97%ef%bc%8c%e4%bb%a5%e8%af%84%e4%bc%b0edison%e7%bb%84%e7%bb%87%e7%a2%8e%e5%8c%96%e7%b3%bb%e7%bb%9f%e5%9c%a8-th/ 2026-07-11T06:34:53+00:00 https://keshavmed.com/news/histosonics%e5%ae%8c%e6%88%90%e9%a6%96%e6%89%b9%e6%82%a3%e8%80%85%e6%b2%bb%e7%96%97%ef%bc%8c%e4%bb%a5%e8%af%84%e4%bc%b0edison%e7%bb%84%e7%bb%87%e7%a2%8e%e5%8c%96%e7%b3%bb%e7%bb%9f%e5%9c%a8-vi/ 2026-07-11T06:34:53+00:00 https://keshavmed.com/news/histosonics%e5%ae%8c%e6%88%90%e9%a6%96%e6%89%b9%e6%82%a3%e8%80%85%e6%b2%bb%e7%96%97%ef%bc%8c%e4%bb%a5%e8%af%84%e4%bc%b0edison%e7%bb%84%e7%bb%87%e7%a2%8e%e5%8c%96%e7%b3%bb%e7%bb%9f%e5%9c%a8-ms/ 2026-07-11T06:34:53+00:00 https://keshavmed.com/news/world-j-urol%ef%bc%9a%e4%b8%80%e9%a1%b9%e4%b8%ba%e6%9c%9f36%e4%b8%aa%e6%9c%88%e7%9a%84%e5%89%8d%e7%9e%bb%e6%80%a7%e7%a0%94%e7%a9%b6%e6%8f%ad%e7%a4%ba%e5%89%8d%e5%88%97%e8%85%ba%e5%a2%9e%e7%94%9f/ 2026-07-11T06:34:53+00:00 https://keshavmed.com/news/world-j-urol%ef%bc%9a%e4%b8%80%e9%a1%b9%e4%b8%ba%e6%9c%9f36%e4%b8%aa%e6%9c%88%e7%9a%84%e5%89%8d%e7%9e%bb%e6%80%a7%e7%a0%94%e7%a9%b6%e6%8f%ad%e7%a4%ba%e5%89%8d%e5%88%97%e8%85%ba%e5%a2%9e%e7%94%9f-zh-tw/ 2026-07-11T06:34:53+00:00 https://keshavmed.com/news/world-j-urol%ef%bc%9a%e4%b8%80%e9%a1%b9%e4%b8%ba%e6%9c%9f36%e4%b8%aa%e6%9c%88%e7%9a%84%e5%89%8d%e7%9e%bb%e6%80%a7%e7%a0%94%e7%a9%b6%e6%8f%ad%e7%a4%ba%e5%89%8d%e5%88%97%e8%85%ba%e5%a2%9e%e7%94%9f-en/ 2026-07-11T06:34:53+00:00 https://keshavmed.com/news/world-j-urol%ef%bc%9a%e4%b8%80%e9%a1%b9%e4%b8%ba%e6%9c%9f36%e4%b8%aa%e6%9c%88%e7%9a%84%e5%89%8d%e7%9e%bb%e6%80%a7%e7%a0%94%e7%a9%b6%e6%8f%ad%e7%a4%ba%e5%89%8d%e5%88%97%e8%85%ba%e5%a2%9e%e7%94%9f-fr/ 2026-07-11T06:34:53+00:00 https://keshavmed.com/news/histosonics%e5%ae%8c%e6%88%90%e9%a6%96%e6%89%b9%e6%82%a3%e8%80%85%e6%b2%bb%e7%96%97%ef%bc%8c%e4%bb%a5%e8%af%84%e4%bc%b0edison%e7%bb%84%e7%bb%87%e7%a2%8e%e5%8c%96%e7%b3%bb%e7%bb%9f%e5%9c%a8-de/ 2026-07-11T06:34:53+00:00 https://keshavmed.com/news/histosonics%e5%ae%8c%e6%88%90%e9%a6%96%e6%89%b9%e6%82%a3%e8%80%85%e6%b2%bb%e7%96%97%ef%bc%8c%e4%bb%a5%e8%af%84%e4%bc%b0edison%e7%bb%84%e7%bb%87%e7%a2%8e%e5%8c%96%e7%b3%bb%e7%bb%9f%e5%9c%a8-ja/ 2026-07-11T06:34:53+00:00 https://keshavmed.com/news/histosonics%e5%ae%8c%e6%88%90%e9%a6%96%e6%89%b9%e6%82%a3%e8%80%85%e6%b2%bb%e7%96%97%ef%bc%8c%e4%bb%a5%e8%af%84%e4%bc%b0edison%e7%bb%84%e7%bb%87%e7%a2%8e%e5%8c%96%e7%b3%bb%e7%bb%9f%e5%9c%a8-pt/ 2026-07-11T06:34:53+00:00 https://keshavmed.com/news/world-j-urol%ef%bc%9a%e4%b8%80%e9%a1%b9%e4%b8%ba%e6%9c%9f36%e4%b8%aa%e6%9c%88%e7%9a%84%e5%89%8d%e7%9e%bb%e6%80%a7%e7%a0%94%e7%a9%b6%e6%8f%ad%e7%a4%ba%e5%89%8d%e5%88%97%e8%85%ba%e5%a2%9e%e7%94%9f-ru/ 2026-07-11T06:34:52+00:00 https://keshavmed.com/news/world-j-urol%ef%bc%9a%e4%b8%80%e9%a1%b9%e4%b8%ba%e6%9c%9f36%e4%b8%aa%e6%9c%88%e7%9a%84%e5%89%8d%e7%9e%bb%e6%80%a7%e7%a0%94%e7%a9%b6%e6%8f%ad%e7%a4%ba%e5%89%8d%e5%88%97%e8%85%ba%e5%a2%9e%e7%94%9f-id/ 2026-07-11T06:34:52+00:00 https://keshavmed.com/news/world-j-urol%ef%bc%9a%e4%b8%80%e9%a1%b9%e4%b8%ba%e6%9c%9f36%e4%b8%aa%e6%9c%88%e7%9a%84%e5%89%8d%e7%9e%bb%e6%80%a7%e7%a0%94%e7%a9%b6%e6%8f%ad%e7%a4%ba%e5%89%8d%e5%88%97%e8%85%ba%e5%a2%9e%e7%94%9f-th/ 2026-07-11T06:34:52+00:00 https://keshavmed.com/news/world-j-urol%ef%bc%9a%e4%b8%80%e9%a1%b9%e4%b8%ba%e6%9c%9f36%e4%b8%aa%e6%9c%88%e7%9a%84%e5%89%8d%e7%9e%bb%e6%80%a7%e7%a0%94%e7%a9%b6%e6%8f%ad%e7%a4%ba%e5%89%8d%e5%88%97%e8%85%ba%e5%a2%9e%e7%94%9f-vi/ 2026-07-11T06:34:52+00:00 https://keshavmed.com/news/world-j-urol%ef%bc%9a%e4%b8%80%e9%a1%b9%e4%b8%ba%e6%9c%9f36%e4%b8%aa%e6%9c%88%e7%9a%84%e5%89%8d%e7%9e%bb%e6%80%a7%e7%a0%94%e7%a9%b6%e6%8f%ad%e7%a4%ba%e5%89%8d%e5%88%97%e8%85%ba%e5%a2%9e%e7%94%9f-ms/ 2026-07-11T06:34:52+00:00 https://keshavmed.com/news/coronavirus-covid-19-update-fda-authorizes-drug-combination-for-treatment-of-covid-19/ 2026-07-11T06:34:52+00:00 https://keshavmed.com/news/coronavirus-covid-19-update-fda-authorizes-drug-combination-for-treatment-of-covid-19-zh-tw/ 2026-07-11T06:34:52+00:00 https://keshavmed.com/news/coronavirus-covid-19-update-fda-authorizes-drug-combination-for-treatment-of-covid-19-fr/ 2026-07-11T06:34:52+00:00 https://keshavmed.com/news/coronavirus-covid-19-update-fda-authorizes-drug-combination-for-treatment-of-covid-19-de/ 2026-07-11T06:34:52+00:00 https://keshavmed.com/news/coronavirus-covid-19-update-fda-authorizes-drug-combination-for-treatment-of-covid-19-ja/ 2026-07-11T06:34:52+00:00 https://keshavmed.com/news/world-j-urol%ef%bc%9a%e4%b8%80%e9%a1%b9%e4%b8%ba%e6%9c%9f36%e4%b8%aa%e6%9c%88%e7%9a%84%e5%89%8d%e7%9e%bb%e6%80%a7%e7%a0%94%e7%a9%b6%e6%8f%ad%e7%a4%ba%e5%89%8d%e5%88%97%e8%85%ba%e5%a2%9e%e7%94%9f-de/ 2026-07-11T06:34:52+00:00 https://keshavmed.com/news/world-j-urol%ef%bc%9a%e4%b8%80%e9%a1%b9%e4%b8%ba%e6%9c%9f36%e4%b8%aa%e6%9c%88%e7%9a%84%e5%89%8d%e7%9e%bb%e6%80%a7%e7%a0%94%e7%a9%b6%e6%8f%ad%e7%a4%ba%e5%89%8d%e5%88%97%e8%85%ba%e5%a2%9e%e7%94%9f-ja/ 2026-07-11T06:34:52+00:00 https://keshavmed.com/news/world-j-urol%ef%bc%9a%e4%b8%80%e9%a1%b9%e4%b8%ba%e6%9c%9f36%e4%b8%aa%e6%9c%88%e7%9a%84%e5%89%8d%e7%9e%bb%e6%80%a7%e7%a0%94%e7%a9%b6%e6%8f%ad%e7%a4%ba%e5%89%8d%e5%88%97%e8%85%ba%e5%a2%9e%e7%94%9f-pt/ 2026-07-11T06:34:52+00:00 https://keshavmed.com/news/world-j-urol%ef%bc%9a%e4%b8%80%e9%a1%b9%e4%b8%ba%e6%9c%9f36%e4%b8%aa%e6%9c%88%e7%9a%84%e5%89%8d%e7%9e%bb%e6%80%a7%e7%a0%94%e7%a9%b6%e6%8f%ad%e7%a4%ba%e5%89%8d%e5%88%97%e8%85%ba%e5%a2%9e%e7%94%9f-es/ 2026-07-11T06:34:52+00:00 https://keshavmed.com/news/world-j-urol%ef%bc%9a%e4%b8%80%e9%a1%b9%e4%b8%ba%e6%9c%9f36%e4%b8%aa%e6%9c%88%e7%9a%84%e5%89%8d%e7%9e%bb%e6%80%a7%e7%a0%94%e7%a9%b6%e6%8f%ad%e7%a4%ba%e5%89%8d%e5%88%97%e8%85%ba%e5%a2%9e%e7%94%9f-ar/ 2026-07-11T06:34:52+00:00 https://keshavmed.com/news/coronavirus-covid-19-update-fda-authorizes-drug-combination-for-treatment-of-covid-19-vi/ 2026-07-11T06:34:51+00:00 https://keshavmed.com/news/coronavirus-covid-19-update-fda-authorizes-drug-combination-for-treatment-of-covid-19-ms/ 2026-07-11T06:34:51+00:00 https://keshavmed.com/news/ec-approves-abbvies-tepkinly-combination-for-follicular-lymphoma/ 2026-07-11T06:34:51+00:00 https://keshavmed.com/news/ec-approves-abbvies-tepkinly-combination-for-follicular-lymphoma-zh-tw/ 2026-07-11T06:34:51+00:00 https://keshavmed.com/news/ec-approves-abbvies-tepkinly-combination-for-follicular-lymphoma-fr/ 2026-07-11T06:34:51+00:00 https://keshavmed.com/news/ec-approves-abbvies-tepkinly-combination-for-follicular-lymphoma-de/ 2026-07-11T06:34:51+00:00 https://keshavmed.com/news/ec-approves-abbvies-tepkinly-combination-for-follicular-lymphoma-ja/ 2026-07-11T06:34:51+00:00 https://keshavmed.com/news/ec-approves-abbvies-tepkinly-combination-for-follicular-lymphoma-pt/ 2026-07-11T06:34:51+00:00 https://keshavmed.com/news/ec-approves-abbvies-tepkinly-combination-for-follicular-lymphoma-es/ 2026-07-11T06:34:51+00:00 https://keshavmed.com/news/ec-approves-abbvies-tepkinly-combination-for-follicular-lymphoma-ar/ 2026-07-11T06:34:51+00:00 https://keshavmed.com/news/coronavirus-covid-19-update-fda-authorizes-drug-combination-for-treatment-of-covid-19-pt/ 2026-07-11T06:34:51+00:00 https://keshavmed.com/news/ec-approves-abbvies-tepkinly-combination-for-follicular-lymphoma-ru/ 2026-07-11T06:34:51+00:00 https://keshavmed.com/news/coronavirus-covid-19-update-fda-authorizes-drug-combination-for-treatment-of-covid-19-es/ 2026-07-11T06:34:51+00:00 https://keshavmed.com/news/ec-approves-abbvies-tepkinly-combination-for-follicular-lymphoma-id/ 2026-07-11T06:34:51+00:00 https://keshavmed.com/news/coronavirus-covid-19-update-fda-authorizes-drug-combination-for-treatment-of-covid-19-ar/ 2026-07-11T06:34:51+00:00 https://keshavmed.com/news/ec-approves-abbvies-tepkinly-combination-for-follicular-lymphoma-th/ 2026-07-11T06:34:51+00:00 https://keshavmed.com/news/coronavirus-covid-19-update-fda-authorizes-drug-combination-for-treatment-of-covid-19-ru/ 2026-07-11T06:34:51+00:00 https://keshavmed.com/news/ec-approves-abbvies-tepkinly-combination-for-follicular-lymphoma-vi/ 2026-07-11T06:34:51+00:00 https://keshavmed.com/news/coronavirus-covid-19-update-fda-authorizes-drug-combination-for-treatment-of-covid-19-id/ 2026-07-11T06:34:51+00:00 https://keshavmed.com/news/ec-approves-abbvies-tepkinly-combination-for-follicular-lymphoma-ms/ 2026-07-11T06:34:51+00:00 https://keshavmed.com/news/coronavirus-covid-19-update-fda-authorizes-drug-combination-for-treatment-of-covid-19-th/ 2026-07-11T06:34:51+00:00 https://keshavmed.com/news/longer-persistence-seen-with-upadacitinib-versus-tnfi-in-rheumatoid-arthritis-zh-tw/ 2026-07-11T06:34:50+00:00 https://keshavmed.com/news/pembrolizumab-belzutifan-tied-to-improved-disease-free-survival-in-renal-cell-carcinoma-ja/ 2026-07-11T06:34:50+00:00 https://keshavmed.com/news/longer-persistence-seen-with-upadacitinib-versus-tnfi-in-rheumatoid-arthritis-fr/ 2026-07-11T06:34:50+00:00 https://keshavmed.com/news/pembrolizumab-belzutifan-tied-to-improved-disease-free-survival-in-renal-cell-carcinoma-pt/ 2026-07-11T06:34:50+00:00 https://keshavmed.com/news/longer-persistence-seen-with-upadacitinib-versus-tnfi-in-rheumatoid-arthritis-de/ 2026-07-11T06:34:50+00:00 https://keshavmed.com/news/pembrolizumab-belzutifan-tied-to-improved-disease-free-survival-in-renal-cell-carcinoma-es/ 2026-07-11T06:34:50+00:00 https://keshavmed.com/news/longer-persistence-seen-with-upadacitinib-versus-tnfi-in-rheumatoid-arthritis-ja/ 2026-07-11T06:34:50+00:00 https://keshavmed.com/news/pembrolizumab-belzutifan-tied-to-improved-disease-free-survival-in-renal-cell-carcinoma-ar/ 2026-07-11T06:34:50+00:00 https://keshavmed.com/news/longer-persistence-seen-with-upadacitinib-versus-tnfi-in-rheumatoid-arthritis-pt/ 2026-07-11T06:34:50+00:00 https://keshavmed.com/news/pembrolizumab-belzutifan-tied-to-improved-disease-free-survival-in-renal-cell-carcinoma-ru/ 2026-07-11T06:34:50+00:00 https://keshavmed.com/news/longer-persistence-seen-with-upadacitinib-versus-tnfi-in-rheumatoid-arthritis-es/ 2026-07-11T06:34:50+00:00 https://keshavmed.com/news/longer-persistence-seen-with-upadacitinib-versus-tnfi-in-rheumatoid-arthritis-ar/ 2026-07-11T06:34:50+00:00 https://keshavmed.com/news/longer-persistence-seen-with-upadacitinib-versus-tnfi-in-rheumatoid-arthritis-ru/ 2026-07-11T06:34:50+00:00 https://keshavmed.com/news/longer-persistence-seen-with-upadacitinib-versus-tnfi-in-rheumatoid-arthritis-id/ 2026-07-11T06:34:50+00:00 https://keshavmed.com/news/longer-persistence-seen-with-upadacitinib-versus-tnfi-in-rheumatoid-arthritis-th/ 2026-07-11T06:34:50+00:00 https://keshavmed.com/news/longer-persistence-seen-with-upadacitinib-versus-tnfi-in-rheumatoid-arthritis-vi/ 2026-07-11T06:34:50+00:00 https://keshavmed.com/news/longer-persistence-seen-with-upadacitinib-versus-tnfi-in-rheumatoid-arthritis-ms/ 2026-07-11T06:34:50+00:00 https://keshavmed.com/news/pembrolizumab-belzutifan-tied-to-improved-disease-free-survival-in-renal-cell-carcinoma/ 2026-07-11T06:34:50+00:00 https://keshavmed.com/news/pembrolizumab-belzutifan-tied-to-improved-disease-free-survival-in-renal-cell-carcinoma-zh-tw/ 2026-07-11T06:34:50+00:00 https://keshavmed.com/news/pembrolizumab-belzutifan-tied-to-improved-disease-free-survival-in-renal-cell-carcinoma-fr/ 2026-07-11T06:34:50+00:00 https://keshavmed.com/news/longer-persistence-seen-with-upadacitinib-versus-tnfi-in-rheumatoid-arthritis/ 2026-07-11T06:34:50+00:00 https://keshavmed.com/news/pembrolizumab-belzutifan-tied-to-improved-disease-free-survival-in-renal-cell-carcinoma-de/ 2026-07-11T06:34:50+00:00 https://keshavmed.com/news/krystal-10-at-esmo-gi-2026-adagrasib-plus-cetuximab-vs-chemotherapy-in-kras-g12c-mutated-mcrc-oncodaily-ar/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/krystal-10-at-esmo-gi-2026-adagrasib-plus-cetuximab-vs-chemotherapy-in-kras-g12c-mutated-mcrc-oncodaily-ru/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/krystal-10-at-esmo-gi-2026-adagrasib-plus-cetuximab-vs-chemotherapy-in-kras-g12c-mutated-mcrc-oncodaily-id/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/krystal-10-at-esmo-gi-2026-adagrasib-plus-cetuximab-vs-chemotherapy-in-kras-g12c-mutated-mcrc-oncodaily-th/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/krystal-10-at-esmo-gi-2026-adagrasib-plus-cetuximab-vs-chemotherapy-in-kras-g12c-mutated-mcrc-oncodaily-vi/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/pembrolizumab-belzutifan-tied-to-improved-disease-free-survival-in-renal-cell-carcinoma-id/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/krystal-10-at-esmo-gi-2026-adagrasib-plus-cetuximab-vs-chemotherapy-in-kras-g12c-mutated-mcrc-oncodaily-ms/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/pembrolizumab-belzutifan-tied-to-improved-disease-free-survival-in-renal-cell-carcinoma-th/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/%f0%9f%8e%89%e3%80%90%e8%af%ba%e5%8d%8e%e6%b3%b0%e8%8f%b2%e4%b9%90%e8%81%94%e5%90%88%e8%bf%88%e5%90%89%e5%ae%81%e8%8e%b7%e6%89%b9%e6%96%b0%e9%80%82%e5%ba%94%e7%97%87%e3%80%91-%e9%87%91/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/pembrolizumab-belzutifan-tied-to-improved-disease-free-survival-in-renal-cell-carcinoma-vi/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/%f0%9f%8e%89%e3%80%90%e8%af%ba%e5%8d%8e%e6%b3%b0%e8%8f%b2%e4%b9%90%e8%81%94%e5%90%88%e8%bf%88%e5%90%89%e5%ae%81%e8%8e%b7%e6%89%b9%e6%96%b0%e9%80%82%e5%ba%94%e7%97%87%e3%80%91-%e9%87%91-zh-tw/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/pembrolizumab-belzutifan-tied-to-improved-disease-free-survival-in-renal-cell-carcinoma-ms/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/%f0%9f%8e%89%e3%80%90%e8%af%ba%e5%8d%8e%e6%b3%b0%e8%8f%b2%e4%b9%90%e8%81%94%e5%90%88%e8%bf%88%e5%90%89%e5%ae%81%e8%8e%b7%e6%89%b9%e6%96%b0%e9%80%82%e5%ba%94%e7%97%87%e3%80%91-%e9%87%91-en/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/krystal-10-at-esmo-gi-2026-adagrasib-plus-cetuximab-vs-chemotherapy-in-kras-g12c-mutated-mcrc-oncodaily/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/%f0%9f%8e%89%e3%80%90%e8%af%ba%e5%8d%8e%e6%b3%b0%e8%8f%b2%e4%b9%90%e8%81%94%e5%90%88%e8%bf%88%e5%90%89%e5%ae%81%e8%8e%b7%e6%89%b9%e6%96%b0%e9%80%82%e5%ba%94%e7%97%87%e3%80%91-%e9%87%91-fr/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/krystal-10-at-esmo-gi-2026-adagrasib-plus-cetuximab-vs-chemotherapy-in-kras-g12c-mutated-mcrc-oncodaily-zh-tw/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/krystal-10-at-esmo-gi-2026-adagrasib-plus-cetuximab-vs-chemotherapy-in-kras-g12c-mutated-mcrc-oncodaily-fr/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/krystal-10-at-esmo-gi-2026-adagrasib-plus-cetuximab-vs-chemotherapy-in-kras-g12c-mutated-mcrc-oncodaily-de/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/krystal-10-at-esmo-gi-2026-adagrasib-plus-cetuximab-vs-chemotherapy-in-kras-g12c-mutated-mcrc-oncodaily-ja/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/krystal-10-at-esmo-gi-2026-adagrasib-plus-cetuximab-vs-chemotherapy-in-kras-g12c-mutated-mcrc-oncodaily-pt/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/krystal-10-at-esmo-gi-2026-adagrasib-plus-cetuximab-vs-chemotherapy-in-kras-g12c-mutated-mcrc-oncodaily-es/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/%f0%9f%8e%89%e3%80%90%e8%af%ba%e5%8d%8e%e6%b3%b0%e8%8f%b2%e4%b9%90%e8%81%94%e5%90%88%e8%bf%88%e5%90%89%e5%ae%81%e8%8e%b7%e6%89%b9%e6%96%b0%e9%80%82%e5%ba%94%e7%97%87%e3%80%91-%e9%87%91-id/ 2026-07-11T06:34:48+00:00 https://keshavmed.com/news/%f0%9f%8e%89%e3%80%90%e8%af%ba%e5%8d%8e%e6%b3%b0%e8%8f%b2%e4%b9%90%e8%81%94%e5%90%88%e8%bf%88%e5%90%89%e5%ae%81%e8%8e%b7%e6%89%b9%e6%96%b0%e9%80%82%e5%ba%94%e7%97%87%e3%80%91-%e9%87%91-th/ 2026-07-11T06:34:48+00:00 https://keshavmed.com/news/%f0%9f%8e%89%e3%80%90%e8%af%ba%e5%8d%8e%e6%b3%b0%e8%8f%b2%e4%b9%90%e8%81%94%e5%90%88%e8%bf%88%e5%90%89%e5%ae%81%e8%8e%b7%e6%89%b9%e6%96%b0%e9%80%82%e5%ba%94%e7%97%87%e3%80%91-%e9%87%91-vi/ 2026-07-11T06:34:48+00:00 https://keshavmed.com/news/%f0%9f%8e%89%e3%80%90%e8%af%ba%e5%8d%8e%e6%b3%b0%e8%8f%b2%e4%b9%90%e8%81%94%e5%90%88%e8%bf%88%e5%90%89%e5%ae%81%e8%8e%b7%e6%89%b9%e6%96%b0%e9%80%82%e5%ba%94%e7%97%87%e3%80%91-%e9%87%91-ms/ 2026-07-11T06:34:48+00:00 https://keshavmed.com/news/%e3%80%8c%e5%b0%91%e9%9d%b6%e7%9c%9f%e6%8e%a2%e8%90%a5%e3%80%8dpfs-%e8%b6%8518-%e4%b8%aa%e6%9c%88%ef%bc%81%e8%be%be%e6%8b%89%e9%9d%9e%e5%b0%bc-%e6%9b%b2%e7%be%8e%e6%9b%bf%e5%b0%bc%e4%ba%8c%e7%ba%bf/ 2026-07-11T06:34:48+00:00 https://keshavmed.com/news/%e3%80%8c%e5%b0%91%e9%9d%b6%e7%9c%9f%e6%8e%a2%e8%90%a5%e3%80%8dpfs-%e8%b6%8518-%e4%b8%aa%e6%9c%88%ef%bc%81%e8%be%be%e6%8b%89%e9%9d%9e%e5%b0%bc-%e6%9b%b2%e7%be%8e%e6%9b%bf%e5%b0%bc%e4%ba%8c%e7%ba%bf-zh/ 2026-07-11T06:34:48+00:00 https://keshavmed.com/news/%e3%80%8c%e5%b0%91%e9%9d%b6%e7%9c%9f%e6%8e%a2%e8%90%a5%e3%80%8dpfs-%e8%b6%8518-%e4%b8%aa%e6%9c%88%ef%bc%81%e8%be%be%e6%8b%89%e9%9d%9e%e5%b0%bc-%e6%9b%b2%e7%be%8e%e6%9b%bf%e5%b0%bc%e4%ba%8c%e7%ba%bf-en/ 2026-07-11T06:34:48+00:00 https://keshavmed.com/news/%e3%80%8c%e5%b0%91%e9%9d%b6%e7%9c%9f%e6%8e%a2%e8%90%a5%e3%80%8dpfs-%e8%b6%8518-%e4%b8%aa%e6%9c%88%ef%bc%81%e8%be%be%e6%8b%89%e9%9d%9e%e5%b0%bc-%e6%9b%b2%e7%be%8e%e6%9b%bf%e5%b0%bc%e4%ba%8c%e7%ba%bf-fr/ 2026-07-11T06:34:48+00:00 https://keshavmed.com/news/%f0%9f%8e%89%e3%80%90%e8%af%ba%e5%8d%8e%e6%b3%b0%e8%8f%b2%e4%b9%90%e8%81%94%e5%90%88%e8%bf%88%e5%90%89%e5%ae%81%e8%8e%b7%e6%89%b9%e6%96%b0%e9%80%82%e5%ba%94%e7%97%87%e3%80%91-%e9%87%91-de/ 2026-07-11T06:34:48+00:00 https://keshavmed.com/news/%f0%9f%8e%89%e3%80%90%e8%af%ba%e5%8d%8e%e6%b3%b0%e8%8f%b2%e4%b9%90%e8%81%94%e5%90%88%e8%bf%88%e5%90%89%e5%ae%81%e8%8e%b7%e6%89%b9%e6%96%b0%e9%80%82%e5%ba%94%e7%97%87%e3%80%91-%e9%87%91-ja/ 2026-07-11T06:34:48+00:00 https://keshavmed.com/news/%f0%9f%8e%89%e3%80%90%e8%af%ba%e5%8d%8e%e6%b3%b0%e8%8f%b2%e4%b9%90%e8%81%94%e5%90%88%e8%bf%88%e5%90%89%e5%ae%81%e8%8e%b7%e6%89%b9%e6%96%b0%e9%80%82%e5%ba%94%e7%97%87%e3%80%91-%e9%87%91-pt/ 2026-07-11T06:34:48+00:00 https://keshavmed.com/news/%f0%9f%8e%89%e3%80%90%e8%af%ba%e5%8d%8e%e6%b3%b0%e8%8f%b2%e4%b9%90%e8%81%94%e5%90%88%e8%bf%88%e5%90%89%e5%ae%81%e8%8e%b7%e6%89%b9%e6%96%b0%e9%80%82%e5%ba%94%e7%97%87%e3%80%91-%e9%87%91-es/ 2026-07-11T06:34:48+00:00 https://keshavmed.com/news/%f0%9f%8e%89%e3%80%90%e8%af%ba%e5%8d%8e%e6%b3%b0%e8%8f%b2%e4%b9%90%e8%81%94%e5%90%88%e8%bf%88%e5%90%89%e5%ae%81%e8%8e%b7%e6%89%b9%e6%96%b0%e9%80%82%e5%ba%94%e7%97%87%e3%80%91-%e9%87%91-ar/ 2026-07-11T06:34:48+00:00 https://keshavmed.com/news/%f0%9f%8e%89%e3%80%90%e8%af%ba%e5%8d%8e%e6%b3%b0%e8%8f%b2%e4%b9%90%e8%81%94%e5%90%88%e8%bf%88%e5%90%89%e5%ae%81%e8%8e%b7%e6%89%b9%e6%96%b0%e9%80%82%e5%ba%94%e7%97%87%e3%80%91-%e9%87%91-ru/ 2026-07-11T06:34:48+00:00 https://keshavmed.com/news/%e3%80%8c%e5%b0%91%e9%9d%b6%e7%9c%9f%e6%8e%a2%e8%90%a5%e3%80%8dpfs-%e8%b6%8518-%e4%b8%aa%e6%9c%88%ef%bc%81%e8%be%be%e6%8b%89%e9%9d%9e%e5%b0%bc-%e6%9b%b2%e7%be%8e%e6%9b%bf%e5%b0%bc%e4%ba%8c%e7%ba%bf-vi/ 2026-07-11T06:34:47+00:00 https://keshavmed.com/news/%e3%80%8c%e5%b0%91%e9%9d%b6%e7%9c%9f%e6%8e%a2%e8%90%a5%e3%80%8dpfs-%e8%b6%8518-%e4%b8%aa%e6%9c%88%ef%bc%81%e8%be%be%e6%8b%89%e9%9d%9e%e5%b0%bc-%e6%9b%b2%e7%be%8e%e6%9b%bf%e5%b0%bc%e4%ba%8c%e7%ba%bf-ms/ 2026-07-11T06:34:47+00:00 https://keshavmed.com/news/dabrafenib-plus-trametinib-in-brafv600e-mutated-rare-cancers-the-phase-2-roar-trial-nature/ 2026-07-11T06:34:47+00:00 https://keshavmed.com/news/dabrafenib-plus-trametinib-in-brafv600e-mutated-rare-cancers-the-phase-2-roar-trial-nature-zh-tw/ 2026-07-11T06:34:47+00:00 https://keshavmed.com/news/dabrafenib-plus-trametinib-in-brafv600e-mutated-rare-cancers-the-phase-2-roar-trial-nature-fr/ 2026-07-11T06:34:47+00:00 https://keshavmed.com/news/dabrafenib-plus-trametinib-in-brafv600e-mutated-rare-cancers-the-phase-2-roar-trial-nature-de/ 2026-07-11T06:34:47+00:00 https://keshavmed.com/news/dabrafenib-plus-trametinib-in-brafv600e-mutated-rare-cancers-the-phase-2-roar-trial-nature-ja/ 2026-07-11T06:34:47+00:00 https://keshavmed.com/news/%e3%80%8c%e5%b0%91%e9%9d%b6%e7%9c%9f%e6%8e%a2%e8%90%a5%e3%80%8dpfs-%e8%b6%8518-%e4%b8%aa%e6%9c%88%ef%bc%81%e8%be%be%e6%8b%89%e9%9d%9e%e5%b0%bc-%e6%9b%b2%e7%be%8e%e6%9b%bf%e5%b0%bc%e4%ba%8c%e7%ba%bf-de/ 2026-07-11T06:34:47+00:00 https://keshavmed.com/news/%e3%80%8c%e5%b0%91%e9%9d%b6%e7%9c%9f%e6%8e%a2%e8%90%a5%e3%80%8dpfs-%e8%b6%8518-%e4%b8%aa%e6%9c%88%ef%bc%81%e8%be%be%e6%8b%89%e9%9d%9e%e5%b0%bc-%e6%9b%b2%e7%be%8e%e6%9b%bf%e5%b0%bc%e4%ba%8c%e7%ba%bf-ja/ 2026-07-11T06:34:47+00:00 https://keshavmed.com/news/%e3%80%8c%e5%b0%91%e9%9d%b6%e7%9c%9f%e6%8e%a2%e8%90%a5%e3%80%8dpfs-%e8%b6%8518-%e4%b8%aa%e6%9c%88%ef%bc%81%e8%be%be%e6%8b%89%e9%9d%9e%e5%b0%bc-%e6%9b%b2%e7%be%8e%e6%9b%bf%e5%b0%bc%e4%ba%8c%e7%ba%bf-pt/ 2026-07-11T06:34:47+00:00 https://keshavmed.com/news/%e3%80%8c%e5%b0%91%e9%9d%b6%e7%9c%9f%e6%8e%a2%e8%90%a5%e3%80%8dpfs-%e8%b6%8518-%e4%b8%aa%e6%9c%88%ef%bc%81%e8%be%be%e6%8b%89%e9%9d%9e%e5%b0%bc-%e6%9b%b2%e7%be%8e%e6%9b%bf%e5%b0%bc%e4%ba%8c%e7%ba%bf-es/ 2026-07-11T06:34:47+00:00 https://keshavmed.com/news/%e3%80%8c%e5%b0%91%e9%9d%b6%e7%9c%9f%e6%8e%a2%e8%90%a5%e3%80%8dpfs-%e8%b6%8518-%e4%b8%aa%e6%9c%88%ef%bc%81%e8%be%be%e6%8b%89%e9%9d%9e%e5%b0%bc-%e6%9b%b2%e7%be%8e%e6%9b%bf%e5%b0%bc%e4%ba%8c%e7%ba%bf-ar/ 2026-07-11T06:34:47+00:00 https://keshavmed.com/news/%e3%80%8c%e5%b0%91%e9%9d%b6%e7%9c%9f%e6%8e%a2%e8%90%a5%e3%80%8dpfs-%e8%b6%8518-%e4%b8%aa%e6%9c%88%ef%bc%81%e8%be%be%e6%8b%89%e9%9d%9e%e5%b0%bc-%e6%9b%b2%e7%be%8e%e6%9b%bf%e5%b0%bc%e4%ba%8c%e7%ba%bf-ru/ 2026-07-11T06:34:47+00:00 https://keshavmed.com/news/%e3%80%8c%e5%b0%91%e9%9d%b6%e7%9c%9f%e6%8e%a2%e8%90%a5%e3%80%8dpfs-%e8%b6%8518-%e4%b8%aa%e6%9c%88%ef%bc%81%e8%be%be%e6%8b%89%e9%9d%9e%e5%b0%bc-%e6%9b%b2%e7%be%8e%e6%9b%bf%e5%b0%bc%e4%ba%8c%e7%ba%bf-id/ 2026-07-11T06:34:47+00:00 https://keshavmed.com/news/%e3%80%8c%e5%b0%91%e9%9d%b6%e7%9c%9f%e6%8e%a2%e8%90%a5%e3%80%8dpfs-%e8%b6%8518-%e4%b8%aa%e6%9c%88%ef%bc%81%e8%be%be%e6%8b%89%e9%9d%9e%e5%b0%bc-%e6%9b%b2%e7%be%8e%e6%9b%bf%e5%b0%bc%e4%ba%8c%e7%ba%bf-th/ 2026-07-11T06:34:47+00:00 https://keshavmed.com/news/dr-fakih-on-the-fda-approval-of-sotorasib-plus-panitumumab-for-kras-g12c-mutated-mcrc-onclive-zh-tw/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/dr-fakih-on-the-fda-approval-of-sotorasib-plus-panitumumab-for-kras-g12c-mutated-mcrc-onclive-fr/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/dr-fakih-on-the-fda-approval-of-sotorasib-plus-panitumumab-for-kras-g12c-mutated-mcrc-onclive-de/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/dr-fakih-on-the-fda-approval-of-sotorasib-plus-panitumumab-for-kras-g12c-mutated-mcrc-onclive-ja/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/dr-fakih-on-the-fda-approval-of-sotorasib-plus-panitumumab-for-kras-g12c-mutated-mcrc-onclive-pt/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/dr-fakih-on-the-fda-approval-of-sotorasib-plus-panitumumab-for-kras-g12c-mutated-mcrc-onclive-es/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/dr-fakih-on-the-fda-approval-of-sotorasib-plus-panitumumab-for-kras-g12c-mutated-mcrc-onclive-ar/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/dabrafenib-plus-trametinib-in-brafv600e-mutated-rare-cancers-the-phase-2-roar-trial-nature-pt/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/dr-fakih-on-the-fda-approval-of-sotorasib-plus-panitumumab-for-kras-g12c-mutated-mcrc-onclive-ru/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/dabrafenib-plus-trametinib-in-brafv600e-mutated-rare-cancers-the-phase-2-roar-trial-nature-es/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/dr-fakih-on-the-fda-approval-of-sotorasib-plus-panitumumab-for-kras-g12c-mutated-mcrc-onclive-id/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/dabrafenib-plus-trametinib-in-brafv600e-mutated-rare-cancers-the-phase-2-roar-trial-nature-ar/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/dr-fakih-on-the-fda-approval-of-sotorasib-plus-panitumumab-for-kras-g12c-mutated-mcrc-onclive-th/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/dabrafenib-plus-trametinib-in-brafv600e-mutated-rare-cancers-the-phase-2-roar-trial-nature-ru/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/dr-fakih-on-the-fda-approval-of-sotorasib-plus-panitumumab-for-kras-g12c-mutated-mcrc-onclive-vi/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/dabrafenib-plus-trametinib-in-brafv600e-mutated-rare-cancers-the-phase-2-roar-trial-nature-id/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/dabrafenib-plus-trametinib-in-brafv600e-mutated-rare-cancers-the-phase-2-roar-trial-nature-th/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/dabrafenib-plus-trametinib-in-brafv600e-mutated-rare-cancers-the-phase-2-roar-trial-nature-vi/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/dabrafenib-plus-trametinib-in-brafv600e-mutated-rare-cancers-the-phase-2-roar-trial-nature-ms/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/dr-fakih-on-the-fda-approval-of-sotorasib-plus-panitumumab-for-kras-g12c-mutated-mcrc-onclive/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/lumakras-sotorasib-in-combination-with-vectibix-panitumumab-fda-approved-for-metastatic-colorectal-cancer-with-kras-g12c-mutation-news-cancerconnect-com-ja/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/lumakras-sotorasib-in-combination-with-vectibix-panitumumab-fda-approved-for-metastatic-colorectal-cancer-with-kras-g12c-mutation-news-cancerconnect-com-pt/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/lumakras-sotorasib-in-combination-with-vectibix-panitumumab-fda-approved-for-metastatic-colorectal-cancer-with-kras-g12c-mutation-news-cancerconnect-com-es/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/lumakras-sotorasib-in-combination-with-vectibix-panitumumab-fda-approved-for-metastatic-colorectal-cancer-with-kras-g12c-mutation-news-cancerconnect-com-ar/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/lumakras-sotorasib-in-combination-with-vectibix-panitumumab-fda-approved-for-metastatic-colorectal-cancer-with-kras-g12c-mutation-news-cancerconnect-com-ru/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/lumakras-sotorasib-in-combination-with-vectibix-panitumumab-fda-approved-for-metastatic-colorectal-cancer-with-kras-g12c-mutation-news-cancerconnect-com-id/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/lumakras-sotorasib-in-combination-with-vectibix-panitumumab-fda-approved-for-metastatic-colorectal-cancer-with-kras-g12c-mutation-news-cancerconnect-com-th/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/lumakras-sotorasib-in-combination-with-vectibix-panitumumab-fda-approved-for-metastatic-colorectal-cancer-with-kras-g12c-mutation-news-cancerconnect-com-vi/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/lumakras-sotorasib-in-combination-with-vectibix-panitumumab-fda-approved-for-metastatic-colorectal-cancer-with-kras-g12c-mutation-news-cancerconnect-com-ms/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/fda-approves-sotorasib-lumakras-combination-for-metastatic-colorectal-cancer-oncology-news-central/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/fda-approves-sotorasib-lumakras-combination-for-metastatic-colorectal-cancer-oncology-news-central-zh-tw/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/dr-fakih-on-the-fda-approval-of-sotorasib-plus-panitumumab-for-kras-g12c-mutated-mcrc-onclive-ms/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/fda-approves-sotorasib-lumakras-combination-for-metastatic-colorectal-cancer-oncology-news-central-fr/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/lumakras-sotorasib-in-combination-with-vectibix-panitumumab-fda-approved-for-metastatic-colorectal-cancer-with-kras-g12c-mutation-news-cancerconnect-com/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/fda-approves-sotorasib-lumakras-combination-for-metastatic-colorectal-cancer-oncology-news-central-de/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/lumakras-sotorasib-in-combination-with-vectibix-panitumumab-fda-approved-for-metastatic-colorectal-cancer-with-kras-g12c-mutation-news-cancerconnect-com-zh-tw/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/fda-approves-sotorasib-lumakras-combination-for-metastatic-colorectal-cancer-oncology-news-central-ja/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/lumakras-sotorasib-in-combination-with-vectibix-panitumumab-fda-approved-for-metastatic-colorectal-cancer-with-kras-g12c-mutation-news-cancerconnect-com-fr/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/fda-approves-sotorasib-lumakras-combination-for-metastatic-colorectal-cancer-oncology-news-central-pt/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/lumakras-sotorasib-in-combination-with-vectibix-panitumumab-fda-approved-for-metastatic-colorectal-cancer-with-kras-g12c-mutation-news-cancerconnect-com-de/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/fda-approves-sotorasib-lumakras-combination-for-metastatic-colorectal-cancer-oncology-news-central-ar/ 2026-07-11T06:34:44+00:00 https://keshavmed.com/news/fda-approval-of-acalabrutinib-plus-venetoclax-brings-an-all-oral-fixed-duration-option-to-frontline-cll-care-onclive-th/ 2026-07-11T06:34:44+00:00 https://keshavmed.com/news/fda-approves-sotorasib-lumakras-combination-for-metastatic-colorectal-cancer-oncology-news-central-ru/ 2026-07-11T06:34:44+00:00 https://keshavmed.com/news/fda-approval-of-acalabrutinib-plus-venetoclax-brings-an-all-oral-fixed-duration-option-to-frontline-cll-care-onclive-vi/ 2026-07-11T06:34:44+00:00 https://keshavmed.com/news/fda-approves-sotorasib-lumakras-combination-for-metastatic-colorectal-cancer-oncology-news-central-id/ 2026-07-11T06:34:44+00:00 https://keshavmed.com/news/fda-approval-of-acalabrutinib-plus-venetoclax-brings-an-all-oral-fixed-duration-option-to-frontline-cll-care-onclive-ms/ 2026-07-11T06:34:44+00:00 https://keshavmed.com/news/fda-approves-sotorasib-lumakras-combination-for-metastatic-colorectal-cancer-oncology-news-central-th/ 2026-07-11T06:34:44+00:00